CIM — Chimera Investment Income Statement
0.000.00%
- $964.60m
- $10.90bn
- $755.73m
- 78
- 95
- 69
- 95
Annual income statement for Chimera Investment, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,197 | 983 | 697 | 742 | 756 |
Cost of Revenue | |||||
Gross Profit | 644 | 620 | 327 | 200 | 232 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,108 | 308 | 1,210 | 615 | 580 |
Operating Profit | 89 | 675 | -513 | 126 | 176 |
Net Income Before Taxes | 89 | 675 | -513 | 126 | 176 |
Provision for Income Taxes | |||||
Net Income After Taxes | 88.9 | 670 | -513 | 126 | 176 |
Net Income Before Extraordinary Items | |||||
Net Income | 88.9 | 670 | -513 | 126 | 176 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 15.1 | 599 | -587 | 52.4 | 90.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.92 | 10.8 | -7.5 | 0.625 | 1.22 |
Dividends per Share |